Fig. 9From: Design, synthesis, in vitro anticancer, molecular docking and SAR studies of new series of pyrrolo[2,3-d]pyrimidine derivativesThe cell distributions in the different phases of the cell cycle (G0/G1- S- G2/M) after 24Â h of treatment with a untreated MCF7 cells, b 14a treated MCF7 cells, c 14b treated MCF7 cellsBack to article page